Radiofrequency Tumor Ablation - Medicare Advantage

This policy covers radiofrequency tumor ablation (RFA), an image‑guided percutaneous or laparoscopic thermal ablation technique, for treatment of select primary and metastatic tumors. Covered indications include select hepatic tumors (eg, hepatocellular carcinoma, colorectal liver metastases, and limited neuroendocrine lesions), renal tumors (T1a and select T1b), osteoid osteoma, symptomatic non‑spinal bone tumors and limited soft‑tissue sarcomas, but coverage requires strict criteria—patients must be noncandidates for or decline surgery, hepatic lesions are generally limited to a single <5 cm or ≤3 lesions each <3 cm with no extrahepatic disease, renal T1a tumors ≤3 cm—and services must meet Medicare “reasonable and necessary” requirements and are excluded for contraindications such as active infection.

"No documentation requirements are stated in the provided document text."